Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

A Summary of the 2020 Gastric Cancer Summit at Stanford University.

About this Publication
Title
A Summary of the 2020 Gastric Cancer Summit at Stanford University.
Pubmed ID
32707045 (View this publication on the PubMed website)
Digital Object Identifier
Publication
Gastroenterology. 2020 Oct; Volume 159 (Issue 4): Pages 1221-1226
Authors
Huang RJ, Koh H, Hwang JH, Summit Leaders
Affiliations
  • Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California.
  • The Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
  • Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, California. Electronic address: jooha@stanford.edu.
Abstract

There exists no coherent national strategy for the early detection or prevention of gastric cancer in the United States (US), even among identified high-risk groups such as Asian Americans, African Americans, Hispanic Americans, and Alaska Native/American Indian peoples. As a result, patients with gastric cancer in the US are diagnosed at later stages and demonstrate worse overall survival compared to nations of East Asia with established screening programs (Table 1). The under-recognition of gastric cancer risk within minority communities is a significant unaddressed healthcare disparity.

Related CDAS Studies
Related CDAS Projects